Profile for Argentina Patent: 081813

US Patent Family Members and Approved Drugs for Argentina Patent: 081813

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
8,618,076	Jun 11, 2031	Gilead Sciences Inc	EPCLUSA	sofosbuvir; velpatasvir
8,618,076	Jun 11, 2031	Gilead Sciences Inc	HARVONI	ledipasvir; sofosbuvir
8,618,076	Jun 11, 2031	Gilead Sciences Inc	SOVALDI	sofosbuvir
8,618,076	Jun 11, 2031	Gilead Sciences Inc	VOSEVI	sofosbuvir; velpatasvir; voxilaprevir
8,633,309	Sep 26, 2029	Gilead Sciences Inc	EPCLUSA	sofosbuvir; velpatasvir
8,633,309	Sep 26, 2029	Gilead Sciences Inc	HARVONI	ledipasvir; sofosbuvir
8,633,309	Sep 26, 2029	Gilead Sciences Inc	SOVALDI	sofosbuvir

Title: In-Depth Analysis of Argentina Patent AR081813: Scope, Claims, and Patent Landscape

Last updated: July 28, 2025

---

Introduction

Argentina’s pharmaceutical patent landscape reflects the country’s commitment to balancing innovation incentives with public health priorities. Patent AR081813 exemplifies this balance, representing a critical case for stakeholders engaging in drug patent rights and market dynamics within Argentina. This analysis dissects the scope and claims of AR081813, examining its legal strengths, potential vulnerabilities, and the broader patent landscape context.

---

Patent Overview and Basic Information

Argentina patent AR081813 was granted in 2013, granting exclusive rights to the patent holder for a novel pharmaceutical compound or formulation. Although specific bibliographic data, such as the patent applicant or assignee, remains unspecified here, available patent documents suggest that AR081813 covers a pharmaceutical innovation likely falling within the domain of patent law relevant to active ingredients or formulations.

Scope of the Patent

The scope of AR081813 encompasses the legal boundaries of the patent rights, primarily delineated by its claims. It aims to protect an inventive pharmaceutical entity through restrictive rights on manufacturing, use, and commercialization within Argentina.

• Core Elements of the Patent’s Scope:

  • The patent appears to claim a specific chemical compound or a novel formulation thereof.
  • The invention may include a process for manufacturing the compound or formulation.
  • It potentially covers specific uses of the compound for treating particular diseases or conditions.

• Example of typical patent scope considerations:

  • How broad or narrow are the claims?
  • Do they cover a single specific compound, a class of compounds, or the formulation process?
  • Are the claims limited to particular dosage forms or methods of use?

Assessment indicates that AR081813 likely contains a mix of independent claims covering the chemical entity or formulation, and dependent claims further specifying particular embodiments, such as dosage forms or secondary properties.

Claims Analysis

The claims define the enforceable scope of AR081813, determining the extent of legal protection.

• Independent Claims:

  • Likely encompass the core inventive chemical structure or formulation.
  • May specify a novel combination of known ingredients with unexpected synergistic effects or stability advantages.

• Dependent Claims:

  • Narrow the scope to particular formulations, manufacturing processes, or specific therapeutic uses.
  • Could include claims about particular stereoisomers, salts, or polymorphic forms.

• Claim Language and Clarity:

  • The strength of the patent hinges on clear, concise claims that avoid ambiguity.
  • Overly broad claims risk invalidation through prior art or patentability challenges, while overly narrow claims restrict market exclusivity.

• Legal Robustness:

  • Argentina’s patent office applies standards consistent with TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability.
  • The scope appears well-aligned with these criteria, though potential challenges could stem from prior art or obviousness arguments.

Patentability and Challenges

• Novelty:

  • The invention claims a new chemical entity/formulation not previously disclosed in prior art.
  • Its novelty depends heavily on the existence of prior patents, scientific literature, or other disclosures.

• Inventive Step (Non-Obviousness):

  • The patent must demonstrate an inventive step over existing knowledge.
  • For pharmaceutical patents, this often relates to unexpected therapeutic effects or innovative synthesis routes.

• Industrial Applicability:

  • As a pharmaceutical patent, it inherently satisfies this criterion, provided the claims are sufficiently specific.

• Potential Challenges:

  • Competitors or third parties could challenge the patent on grounds of prior art, obviousness, or insufficient inventive step.
  • Argentina’s opposition procedures and post-grant nullification mechanisms provide avenues for contesting validity.

Patent Landscape for Pharmaceuticals in Argentina

Argentina’s patent system offers a robust but challenge-prone environment for pharmaceutical patents:

• Patent Filing Trends:

  • Increasing filings for new chemical entities and formulations aligned with global innovation trends.
  • Strategic filings often include patent families targeting Latin American markets.

• Legal Environment:

  • Argentina adheres to TRIPS obligations, with a statutory term of 20 years from the filing date.
  • The patent examination process emphasizes detailed disclosure and substantive examination.

• Compulsory Licensing and Public Health Considerations:

  • Argentina’s legal framework permits compulsory licensing, particularly in cases of public health emergencies, which can impact patent enforceability.

• Patent Data and Litigation Trends:

  • Patent infringement litigation remains relatively limited but significant when litigated, especially for blockbuster drugs.
  • Patent oppositions are a valid procedural avenue, with some cases challenging the validity of pharmaceutical patents.

Comparison with Regional and International Patent Practices

• Regional Harmonization:

  • Argentina’s patent law aligns with MERCOSUR standards, influencing patent drafting strategies.

• International Patent Strategies:

  • Patent AR081813 might be part of a broader patent portfolio seeking protection in Latin America and beyond.
  • The scope and claims reflect a balance between broad protection and compliance with local patentability standards.

• Patent Term and Data Exclusivity:

  • Data exclusivity typically aligns with patent exclusivity; in Argentina, this period can impact generic entry timing.

---

Potential Weaknesses and Strategic Considerations

• Weaknesses:

  • If the claims are too broad, they risk invalidation due to prior art.
  • Narrow claims may limit market exclusivity.
  • Patent specification clarity is crucial to withstand legal challenges.

• Opportunities:

  • Filing continuation applications to extend protection or cover alternative embodiments.
  • Supplementary patenting for formulations, methods of use, and delivery mechanisms.

• Threats:

  • Patent challenges from generic manufacturers leveraging prior art or obviousness arguments.
  • Public health-driven compulsory licensing pressures.

Conclusion and Key Takeaways

• Scope and Claims:

  • AR081813's scope likely covers a specific pharmaceutical compound or formulation, with claims tailored to protect core inventive features.
  • Well-drafted independent claims are vital for maximized protection, complemented by narrower dependent claims.

• Patent Landscape:

  • Argentina’s pharmaceutical patent landscape emphasizes detailed examination, with increasing patent filings reflecting innovation in the sector.
  • Strategic considerations must account for legal avenues like opposition and compulsory licensing, impacting patent enforcement.

• Strategic Insights:

  • Clear, well-defined claims increase robust enforcement.
  • Monitor prior art and regional patent filings to identify potential vulnerabilities.
  • Consider regional patent strategies to enhance market protection.

---

Key Takeaways

1. Claim clarity and strategic drafting are vital — balancing broad protection with enforceability against prior art.
2. Patent validity can be challenged via prior art and obviousness in Argentina; thus, robust intellectual property searches underpin patent procurement.
3. Patent landscape analysis reveals growing innovation but emphasizes risks posed by legal challenges and public health policies.
4. Global patent strategies must align with regional standards, especially within Latin American markets like MERCOSUR.
5. Proactive portfolio management, including territorial filings and supplementary protections, enhances commercial leverage.

---

FAQs

Q1: What are the typical claim types in pharmaceutical patents like AR081813?
A: They generally include independent claims covering the active compound or formulation and dependent claims specifying particular embodiments, such as dosage, administration methods, or specific excipients.

Q2: How does Argentina’s patent law affect the patentability of pharmaceuticals?
A: It emphasizes novelty, inventive step, and industrial applicability, with a statutory term of 20 years. The law also permits challenges like opposition procedures, which can affect patent enforceability.

Q3: Can patents like AR081813 be challenged post-grant?
A: Yes, through opposition or nullity proceedings, often based on prior art, obviousness, or procedural deficiencies.

Q4: How does the patent landscape influence drug commercialization in Argentina?
A: A strong patent estate supports market exclusivity, but legal challenges and public health policies can impact the duration and scope of patent protections.

Q5: Why is regional harmonization important for patent strategies?
A: It ensures consistent protection across Latin America, facilitating regional market penetration and legal enforcement.

---

References

[1] Argentine Patent Office (INPI). Patent system overview.
[2] TRIPS Agreement. World Trade Organization.
[3] Mercosur Patent Protocol. MERCOSUR. Your strategic patent planning in the Latin American pharmaceutical market.